MENU
CRMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CorMedix (CRMD) Earnings Date & Reports

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions... Show more

A.I. Advisor
published Earnings

CRMD is expected to report earnings to fall 41.61% to 73 cents per share on March 31

CorMedix CRMD Stock Earnings Reports
Q4'25
Est.
$0.74
Q3'25
Beat
by $0.83
Q2'25
Beat
by $0.12
Q1'25
Beat
by $0.14
Q4'24
Beat
by $0.05
The last earnings report on November 12 showed earnings per share of $1.26, beating the estimate of 43 cents. With 5.98M shares outstanding, the current market capitalization sits at 883.23M.
View a ticker or compare two or three
CRMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRMD showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of medical devices for cardiovascular and kidney diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
300 Connell Drive
Phone
+1 908 517-9500
Employees
83
Web
https://www.cormedix.com